• Cadrenal Therapeutics Chief Medical Officer James J. Ferguson III resigned, effective July 31, 2026.
• The board was notified on July 7, 2026.
• A search is underway for a replacement.
• Separation terms are being negotiated, with a separation agreement and release planned.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-077134), on July 10, 2026, and is solely responsible for the information contained therein.